TriPath Imaging Announces Early Termination of Hart-Scott-Rodino Waiting Period and Stockholder Meeting Date
31 October 2006 - 8:51AM
PR Newswire (US)
BURLINGTON, N.C., Oct. 30 /PRNewswire-FirstCall/ -- TriPath
Imaging, Inc. (NASDAQ:TPTH) today announced that on October 26,
2006, the Federal Trade Commission approved the early termination
of the antitrust waiting period under the Hart-Scott-Rodino Act for
the proposed acquisition of TriPath Imaging by BD (Becton,
Dickinson and Company). The closing of the transaction remains
subject to customary conditions, including approval of TriPath
Imaging's stockholders. The special meeting of stockholders of
TriPath Imaging to consider and vote on the adoption of the merger
agreement is scheduled for December 19, 2006. Holders of record of
TriPath Imaging common stock as of the close of business on October
25, 2006, the record date for the special meeting, are entitled to
receive notice of and to vote at the special meeting. About TriPath
Imaging TriPath Imaging, Inc., headquartered in Burlington, North
Carolina, develops, manufactures, markets and sells innovative
solutions to improve the clinical management of cancer, including
detection, diagnosis, staging and treatment. TriPath Oncology, a
wholly owned subsidiary of TriPath Imaging, develops molecular
diagnostic products for malignant melanoma and cancers of the
cervix, breast, ovary and prostate. IMPORTANT ADDITIONAL
INFORMATION WILL BE FILED WITH THE SEC TriPath Imaging plans to
file with the SEC and mail to its stockholders a definitive Proxy
Statement in connection with the transaction. The definitive Proxy
Statement will contain important information about BD, TriPath
Imaging, the transaction and related matters. Investors and
security holders are urged to read the definitive Proxy Statement
carefully when it is available. Investors and security holders will
be able to obtain free copies of the definitive Proxy Statement and
other documents filed with the SEC by BD and TriPath Imaging
through the web site maintained by the SEC at http://www.sec.gov/.
In addition, investors and security holders will be able to obtain
free copies of the definitive Proxy Statement from TriPath Imaging
by contacting TriPath Imaging, Inc., Investor Relations, 780
Plantation Drive, Burlington, NC 27215. TriPath Imaging and its
directors and executive officers may be deemed to be participants
in the solicitation of proxies in respect of the transactions
contemplated by the merger agreement. Information regarding TriPath
Imaging's directors and executive officers is contained in TriPath
Imaging's Form 10-K for the year ended December 31, 2005, its proxy
statement for the 2006 annual meeting of stockholders, its Reports
on Form 8-K filed with the SEC on June 30, 2006, July 25, 2006 and
September 8, 2006 and its preliminary Proxy Statement filed with
the SEC on October 17, 2006. As of October 9, 2006, TriPath
Imaging's directors and executive officers beneficially owned
approximately 2,099,959 shares, or 5.4%, of TriPath Imaging's
common stock. A more complete description will be available in the
definitive Proxy Statement. SAFE HARBOR FOR FORWARD-LOOKING
STATEMENTS Statements in this document regarding the proposed
transaction between BD and TriPath Imaging, the expected timetable
for completing the transaction, benefits of the transaction, future
opportunities for the combined company and any other statements
about TriPath Imaging managements' future expectations, beliefs,
goals, plans or prospects constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Any statements that are not statements of historical fact
(including statements containing the words "believes," "plans,"
"anticipates," "expects," "estimates" and similar expressions)
should also be considered to be forward- looking statements. There
are a number of important factors that could cause actual results
or events to differ materially from those indicated by such
forward-looking statements, including: the need for approval of the
transaction by TriPath stockholders, the ability to consummate the
transaction; the ability to realize anticipated efficiencies and
opportunities; and other factors described in TriPath Imaging's
Annual Report on Form 10-K for the year ended December 31, 2005 and
its most recent quarterly report filed with the SEC. Contact
Stephen P. Hall Chief Financial Officer 336-290-8721 DATASOURCE:
TriPath Imaging, Inc. CONTACT: Stephen P. Hall, Chief Financial
Officer of TriPath Imaging, Inc., +1-336-290-8721 Web site:
http://www.tripathimaging.com/
Copyright
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Sep 2023 to Sep 2024